可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Araszkiewicz A,Grygier M,Lesiak M,et al.The impact of ischemia-reperfusion injury on the effectiveness of primary angioplasty in ST-segment elevation myocardial infarction[J].Postepy Kardiol Interwencyjnej,2013,3(33):275-281.
[2]李红昆.内皮细胞微粒与冠心病关系的研究进展[J].广西医学,2013,35(1):104-106.
[3]Dehmer GJ,Blankenship JC,Cilingiroglu M,et al.SCAI/ACC/AHA expert consensus document:2014 update on percutaneous coronary intervention without on-site surgical backup[J].Circulation,2014,129(24):2610-2626.
[4]Fr?hlich GM,Meier P,White SK,et al.Myocardial reperfusion injury:looking beyond primary PCI[J].Eur Heart J,2013,34(23):1714-1722.
[5]Smadja DM,Gaussem P,Mauge L,et al.Comparison of endothelial biomarkers according to reversibility of pulmonary hypertension secondary to congenital heart disease[J].Pediatr Cardiol,2010,31(5):657-662.
[6]Dursun I,Dusunsel R,Poyrazoglu HM,et al.Circulating endothelial microparticles in children with Henoch-Schonlein purpura;preliminary results[J].Rheumatol Int,2011,31(12):1595-1600.
[7]Moens AL,Claeys MJ,Timmermans JP,et al.Myocardial ischemia/reperfusion-injury,a clinical view on a complex pathophysiological process[J].Int J Cardiol,2005,100(2):179-190.
[8]Celik T,Kaya MG,Akpek M,et al.Events in acute ST-Segment elevation myocardial infarction predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular[J].Angiology,2014,65(3):24301422.
[9]Kumar S,Sivagangabalan G,Thiagalingam A,et al.Effect of reperfusion time on inducible ventricular tachycardia early and spontaneous ventricular arrhythmias late after ST elevation myocardial infarction treated with primary percutaneous coronary intervention[J].Heart Rhythm,2011,8(4):493-499.
[10]Thuc LC,Teshima Y,Takahashi N,et al.Cardioprotective effects of pravastatin against lethal ventricular arrhythmias induced by reperfusion in the rat heart[J].Circulation Journal,2011,75(7):1601-1608.
[11]谢培益,祁述善,周胜华,等.校正TIMI帧数对急诊PCI术后ST段回落及急性心肌梗死患者短期预后的评价[J].中国现代医学杂志,2005,15(6):921-923.
[12]Mallat Z,Benamer H,Hugel B,et al.Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes[J].Circulation,2000,101(8):841-843.
[13]Bernal-Mizrachi L,Jy W,Jimenez JJ,et al.High levels of circulating endothelial microparticles in patients with acute coronary syndromes[J].Am Heart J,2003,145(6):962-970.
[14]Sai C,Shu ZL.The Na+/Ca2+ exchanger in cardiac ischemia/reperfusion injury[J]. Med Sci Monit,2012,18(11):161-165.
[15]Sharma V,Bell RM,Yellon DM.Targeting reperfusion injury in acute myocardial infarction:a review of reperfusion injury pharmacotherapy[J].Expert Opin Pharmacother,2012,13(8):1153-1175.
[16]Leroyer AS,Anfosso F,Lacroix R,et al.Endothelial-derived microparticles:Biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis[J].Thromb Haemost,2010,104(3):456-463.